Burnaby company granted Health Canada licence to produce 'magic mushroom' medicine
At Burnaby’s Albert Labs, it’s science meets nature. On the walls, you’ll find posters of various mushrooms next to scientific formulas, symbolizing the company's mission to develop mental health medicine derived from natural substances. The small team of around 20 employees recently received a Health Canada license to further pursue its work in producing psilocybin from mushrooms.
“Oh, it’s very big,” said Ali Gulamhusein, chief development officer for Albert Labs.
“That licence grants us the ability to produce, manufacture, export and import psilocybin.”
Gulamhusein refers to psilocybin as the magic medicine of the magic mushroom. The company also operates in the U.K. and Portugal, and plans to begin clinical trials in the U.K. this fall.
“(The) first early indications that we’re targeting is cancer-related anxiety,” said Gulamhusein, who adds that the company also hopes to treat people with depression, anxiety and PTSD.
Gulamhusein says the process involves isolating the psilocybin from the root and bio-engineering the drug in a controlled setting to help ensure consistency.
The company’s CEO says studies of the treatment have been overwhelmingly positive, calling psilocybin a potential game changer when it comes to mental illness therapy.
“One dose – and associated psychotherapy – cures anxiety for many months, and in some cases, permanently,” said Dr. Michael Raymont.
But it’s currently only available for Canadians with special permission from doctors. Christine Parlee lives with terminal stage four cancer and was granted permission for treatment to help ease her severe anxiety.
“It was phenomenal, probably one of the best experiences of my life to be honest,” said Parlee via Zoom from her home in Duncan.
“To say it changed me down to the bottom of my core is putting it mildly.”
One expert tells CTV News that despite high demand from patients, it could take two to three years before psychedelics become a common, more accessible treatment.
“I think there’s a lot of work to be done in training of professionals in understanding this new paradigm in mental health treatment,” said Dr. Devon Christie, senior lead of psychedelic programs at Numinus.
Meanwhile, if all goes well in the U.K., Albert Labs hopes to have its drug ready for trial in Canada by 2023.
CTVNews.ca Top Stories
B.C. seeks ban on public drug use, dialing back decriminalization
The B.C. NDP has asked the federal government to recriminalize public drug use, marking a major shift in the province's approach to addressing the deadly overdose crisis.
Orca calf that was trapped in B.C. lagoon for weeks swims free
An orca whale calf that has been stranded in a B.C. lagoon for weeks after her pregnant mother died swam out on her own early Friday morning.
Trump's lawyers try to discredit testimony of prosecution's first witness in hush money trial
Donald Trump's defence team attacked the credibility Friday of the prosecution's first witness in his hush money case, seeking to discredit testimony detailing a scheme between Trump and a tabloid to bury negative stories to protect the Republican's 2016 presidential campaign.
Sophie Gregoire Trudeau on navigating post-political life, co-parenting and freedom
Sophie Gregoire Trudeau says there is 'still so much love' between her and Prime Minister Justin Trudeau, as they navigate their post-separation relationship co-parenting their three children.
More than 115 cases of eye damage reported in Ontario after solar eclipse
More than 115 people who viewed the solar eclipse in Ontario earlier this month experienced eye damage after the event, according to eye doctors in the province.
'I was scared': Ontario man's car repossessed after missing two repair loan payments
An Ontario man who took out a loan to pay for auto repairs said his car was repossessed after he missed two payments.
Last letters of pioneering climber who died on Everest reveal dark side of mountaineering
George Mallory is renowned for being one of the first British mountaineers to attempt to scale the dizzying heights of Mount Everest during the 1920s. Nearly a century later, newly digitized letters shed light on Mallory’s hopes and fears about ascending Everest.
Air traveller complaints to Canadian Transportation Agency hit new high
The Canadian Transportation Agency has hit a record high of more than 71,000 complaints in a backlog. The quasi-judicial regulator and tribunal tasked with settling disputes between customers and the airlines says the backlog is growing because the number of incoming complaints keeps increasing.
U.S. flight attendant indicted in attempt to record teen girl in airplane bathroom
An American Airlines flight attendant was indicted Thursday after authorities said he tried to secretly record video of a 14-year-old girl using an airplane bathroom last September.